Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients

Ji-Won MIN; Hyeyoung LEE; Bum-Soon CHOI; Cheol-Whee PARK; Chul-Woo YANG; Yong-Soo KIM; Yeong-Jin CHOI; Eun-Jee OH; Byung-Ha CHUNG.
Annals of Laboratory Medicine ; : 450-457, 2018.
Artículo en Inglés | WPRIM | ID: wpr-717054

Documentos relacionados

  1. Effect of anti-angiotensin II type 1 receptor antibodies on the outcomes of kidney transplantation: a systematic review and meta-analysis.
  2. Nanobody-Mediated Dualsteric Engagement of the Angiotensin Receptor Broadens Biased Ligand Pharmacology.
  3. Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell Proliferation.
  4. Clinical conundrums in pediatric kidney transplantation: What we know about the role of angiotensin II type I receptor antibodies in pediatric kidney transplantation and the path forward.
  5. Differential Contribution of Transmembrane Domains IV, V, VI, and VII to Human Angiotensin II Type 1 Receptor Homomer Formation.
  6. Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting.
  7. Kidney re-transplantation in a child across the barrier of persisting angiotensin II type I receptor antibodies.
  8. Angiotensin Analogs with Divergent Bias Stabilize Distinct Receptor Conformations.
  9. Autoantibodies Targeting G-Protein-Coupled Receptors: Pathogenetic, Clinical and Therapeutic Implications in Systemic Sclerosis.
  10. Autoantibodies against angiotensin and adrenergic receptors: more than a biomarker?